Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Curosurf approved in U.S. for treatment of RDS in premature infants

Nov. 25, 1999

Sepracor and Abbott to copromote Xopenex in the U.S.

Nov. 22, 1999

Dual NK1/NK2 antagonist examined for disposition in rats

Nov. 22, 1999

RPR's new cell adhesion inhibitors especially useful for asthma, joint inflammation and IBD

Nov. 22, 1999

Potent, selective and stable tryptase inhibitors developed at Protherics

Nov. 22, 1999

Fournier's new bradykinin antagonists particularly useful for asthma, rhinitis

Nov. 16, 1999

Schering-Plough presents dual NK1/NK2 antagonists and their use in asthma, allergies, etc.

Nov. 16, 1999

Interferon gamma-1b offers possibilities as treatment for idiopathic pulmonary fibrosis

Nov. 15, 1999

Acetamide derivatives as chymase inhibitors patented by Nippon Kayaku

Nov. 11, 1999

Esteve sublicenses Surfaxin from Discovery for southern European territories, Latin America

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...